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A growth factor has been isolated from HTCSR rat hepatoma tissue culture 
cells which specifically stimulates DNA synthesis and cell proliferation of the 
HTC cells that produce it. The factor can be isolated from HTC cell condi-
tioned medium or from an HTC cell extract. This autocrine factor has been 
purified 640-fold from a postmicrosomal supernatant by successive steps, 
involving ethanol precipitation, heating at 80°C for 10 min, chromatography 
on a DEAE Bio-Gel A column, and chromatography on a heparin-sepharose 
affinity column. The major peak of activity eluted from the heparin column 
migrates as a single band on SDS-PAGE with an apparent M, of 60,000. The 
factor is resistant to acid, heat, and neuraminidase but sensitive to trypsin, 
papain, and protease. 
The autocrine nature of the factor is indicated by the finding that several 
other types of cells do not respond with increased DNA synthesis. Mouse l-
cells, BHK cells, Novikoff hepatoma cells, hepatocytes in primary culture, and 
an epithelial-like rat liver-derived cell line (Clone 9) were tested, and none of 
the cells could be stimulated. Small amounts of the factor could be extracted 
from the Clone 9 cells, however. This material had the same physical and 
purification properties as the factor extracted from HTC cells, but it did not 
stimulate DNA synthesis in Clone 9 cells, only in HTC cells. 
Addition of the factor resulted in an almost immediate stimulation of DNA 
synthesis in a ~roliferating HTC cell population. When the factor was added 
together with [ H)thymidine for 2 h, a significant stimulation of DNA synthesis 
was observed, provided the addition was made between 18 and 48 h after the 
cells had been plated. Autoradiographic studies indicated that the factor both 
accelerates DNA synthesis in cells already making DNA and increases the 
number of cells entering the S period. The stimulation of DNA synthesis was 
completely inhibited by 10 mM hydroxyurea, whether the factor was present 
for 2, 24, or 48 h in the culture. A significant increase in cell number due to 
addition of the factor was also observed. This accelerated proliferation was 
detectable only after the cells had been in culture for at least 48 h with the 
factor present. 
Growth of mammalian cells seems to be regulated to 
a large extent by hormones and growth factors which 
are present in serum, as well as in other tissue fluids. In 
addition, there seem to be growth inhibitors in various 
tissue fluids contributing to the complexity of the regu-
latory process (O'Keefe and Pledger, 1983; Moses et al., 
1985). Some of the growth factors are produced by spe-
cific tissues or cells in the organism and might affect a 
variety of cells throughout the organism. Others seem 
to be produced by the same cells that are also responsive 
to them <Kaplan et al., 1982; Sporn and Todaro, 1980; 
Sporn and Roberts, 1985). Several excellent review arti-
cles have discussed many of the various growth factors 
and their properties (O'Keefe and Pledger, 1983; Moses 
et aI., 1985; Holley, 1974; Antoniades and Owen, 1982; 
Goustin et aI., 1986; Ciba Symposium, 1985). • 
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It has been known for some time that malignant cells 
seem to require fewer exogenous growth factors for op-
timal multiplication and growth than their cells of ori-
gin (Antoniades and Owen, 1982; Holley, 1975). 
Primarily by comparing 3T3 cells and virally trans-
formed 3T3 cells in culture, it was shown that different 
serum concentrations and possibly different serum com-
ponents were required to maintain and grow these cells 
(Holley, 1974; Antoniades and Owen, 1982; Holley, 1975). 
In general, much lower serum concentrations were 
needed to grow the virally transformed cells as well as 
other tumor cell lines (Antoniades and Owen, 1982). In 
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recent years, an explanation for this self-sufficiency of 
malignant cells has emerged. It has been suggested that 
malignant cells can produce growth factors which act on 
their producer cells via external receptors (Kaplan et 
aI., 1982; Sporn and Todaro, 1980; Burk, 1973· Todaro et 
aI., 1976). This process is now referred to as :'autocrine 
secretion" and provides an explanation for the ability of 
oncogenes to make cancer cells autonomous of exoge-
nous growth factors (Sporn and Todaro, 1980; Sporn and 
Roberts., 1985). 
po~e of the first evidence ~or endogenous growth fac-
tors 10 tumor cells was proVIded with murine sarcoma 
virus transformed cells (Ozanne et aI., 1980; DeLarco 
and Todaro, 1978). It was subsequently shown that these 
sarcoma growth factors were structurally related to but 
distinct from, epidermal growth factor (EGF). The EGF-
like substances competed with authentic EGF for EGF 
receptors (Ozanne et aI., 1980; Roberts et aI., 1983). 
Soon, similar growth factors, now collectively referred 
to as transforming growth factors (TGF) were found in 
the conditioned medium of various cultur'ed transformed 
cells (Sporn and Todaro, 1980; Ozanne et al., 1980; Rob-
erts et aI., 1980; Todaro et aI., 1980). Two molecular 
species have been identified, a 25 kDa qdc-~ and a 5.6 
kDa TGF -<X. These factors have also been isolated from 
mouse embryos (Proper et aI., 1982). TGF -<X has been 
demonstrated in human placenta (Stromberg et al., 1982) 
and in mouse embryo (Twardzik et aI., 1982), and a 
platelet-derived qdc-~ has been purified (Childs et aI., 
1982). Human cancer cells produce and release TGF and 
have functional receptors for the peptides (Todaro et aI., 
1980; Marquardt and Todaro, 1982; Halper and Moses 
1983; Richmond et aI., 1983). ' 
We report the isolation and partial purification of a 
factor from rat hepatoma HTC-SR cells. This factor is 
produced by the HTC cells and stimulates DNA synthe-
sis an~ ~wth specifically in these cells, thus meeting 
the cntena for an autocrine factor. 
MATERIALS AND METHODS 
Materials 
Dulbecco's Modified Eagle's medium roME), Ham's F-
12 medium, fetal bovine serum (PBS), antibioticJanti-
mycotic, and trypsin were obtained from GmCO Labo-
ratories, Grand Island, NY. DEAE Bio-Gel A was 
obtained from Bio-Rad Laboratories, Richmond CA and 
heparin-sepharose CL-6B from Pharmacia, fn~KI Pisca-
taway, NJ. [3H)Thymidine (60-80 Ci/mmol) was pur-
chased from New England Nuclear Research Products, 
Boston, MA. Other chemicals and enzymes were pur-
chased from Sigma Chemical Company, St. Louis, MO_ 
Cell lines and culture conditions 
HTC-SR rat hepatoma cells (a clonal line from Morris 
hepatoma 7288C) were a generous gift. from Dr. H. Bau-
mann, Department of Tumor Biology, Roswell Park Me-
morial lnstitute. Buffalo, NY. Stock cultures were 
maintained in DME supplemented with 1()t1, FBS and 
antibiotic/antimycotic in loo-mm dishes at 37°C and a 
5% CO2 atmosphere. 
Clone 9 normal rat liver cells were obtained from the 
American Type Culture Collection, Rockville, MD. Stock 
cultures were grown in Ham's F-12 medi)lDl, 10% FBS 
and antibiotic/antimycotic at 37°C and a 5% CO2 
atmosphere. 
( ( 04 
Cell bioassays 
Determination of [3l1]thymidine incorporation. For 
the routine cell bioassay, stock cultures were subcul-
tured when cells were not yet confluent and distributed 
at a cell density of 5 x 104 cells per 35-mm tissue culture 
dish in 2 ml complete medium required for that partic-
ular cell type. The medium was supplemented with 10% 
c~ ~nless indic:ated Kot~erwiseK Fractions, previously 
sterIlized by UV IrradiatIon, were added at the time of 
plating. The cells were left. at 37°C and a 5% CO2 atmo-
sphere for 48 h with no additional medium change. The 
ce~ls were exposed to 0.4 ",Ci/dish [3H]thymidine for 2 h 
pnor to harvest, unless otherwise indicated. 
.For harvesting, the cells were scraped into the me-
dIUm and t~e dishes scraped again with 1 ml phosphate 
buffered salIne (PBS). The rinse was combined with the 
cell suspension and centrifuged for 10 min at 5,OOOg. 
The .cell pellet was solubilized in 1 ml 1 M NaOH by 
heatmg at 80°C for 10 min. DNA was precipitated by 
5% trichloroacetic acid and collected on a Celite filter 
aid covered filter paper and radioactivity determined as 
previously described (Ove et aI., 1971). 
IJ;l ~hose experime~~ designed to test the stimulatory 
actIVIty of the conditIoned medium, cells were subcul-
tured as above, but were plated at a cell density of 5 x 
104 cells per 35-mm dish in 0.5 ml DME:l()t1, FBS. Con-
ditioned medium was added at the concentrations indi-
cated, and serum-free DME added to a final volume of 
2.0 ml per dish. The final FBS concentration was 2.5%. 
Exposure to [3H)thymidine and harvesting of cells was 
as described above. 
Conditioned medium 
To obtain conditioned medium, HTC cells were plated 
at a ~ensity of 104 cellslcm2 in regular growth medium 
and mcubated. After 48 h, the cells were washed twice 
with serum-free DME and then incubated in serum-free 
medium. After 24 h, the medium was collected, centri-
f~ged to .remove floating cells, and sterilized by filtra-
tIon. Vanous concentrations of this medium were tested 
for stimulatory activity in the [3H]thymidine incorpora-
tion assay. 
Some conditioned medium was brought to 70% in 
eth~olI and the resulting precipitate was collected and 
subjected to the same purification procedures as the 
HTC cell extract. 
Cell growth determination 
Cells were subcultured as described above and plated 
at a cell density of 1.25 x 104 cells per 35-mm culture 
dish. Fractions (5 ",g Bio-Gel F4) were added at the time 
of plating. On day 3, one-half of the experimental dishes 
received an additional aliquot of factor. At the times 
indicated, the medium was removed and the cells col-
lected by mild trypsinization, and the cell number deter-
mined with a Coulter counter. 
Extraction and purification of autocrine factor 
HTC cells were grown in loo-mm dishes in complete 
medium and harvested for extraction when not con-
fluent 48-72 h after subculturing. The dishes were 
washed three times with PBS and the cells scraped into 
extraction buffer, 250 roM sucrose: 10 roM Tria, pH 7.4: 
10 roM EDTA according to the method of Hata8e et aI_ 
(1979). Following homogenization, the cell suspension 
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was centrifuged at 10,OOOg for 10 min. The supernatant TABLE 1. The effect of conditioned medium from HTC cells on 
was subsequently centrifuged for 1 h at 100,OOOg, and ,3Hlthymidine incorporation in HTC and Clone 9 cells' 
the postmicrosomal supernatant brought to 70% in ,3H]thymidine incorporation 
ethanol. After 2 h in ice, the precipitate was collected by Conditioned (cpmll05 cells) 
centrifugation at 10,OOOg for 10 min and dissolved in medium (%) HTC cells Clone 9 cells 
H20. Following a 10-min heating at 80°C, any precipi- o ---------------------
tate that formed was collected by centrifugation at 25 1,426 ± 782 964 ± 102 1,740 ± 196 853 ± 36 
10,OOOg for 10 min and discarded. An aliquot of the 50 2,367 ± 141 951 ± 136 
supernatant was sterilized by UV irradiation for the cell .;.,;75'---______ --=P~IS:=O=_O -=±....;3:=10=--____ -=8.:..:17:...,;±::....:..:75=__ 
bioassay and the remainder stored at - 20°C for further 
purification. 
DEAE Bio-Gel A chromatography 
Four milligrams protein of saoc supernatant were 
applied to a 10-cm x 1-cm column equilibrated with 5 
roM Tris-HCl, pH 7.6. Four-milliliter fractions were col-
lected. The column was washed with 20 ml 5 roM Tris-
HCl, pH 7.6, and eluted stepwise with 20 ml each 100 
roM NaCl, 250 roM NaCl, and 500 roM NaCl, each in 5 
roM Tris, pH 7.6. The peak fractions, as determined by 
absorbance at 280 nm, were combined, lyophilized, dis-
solved in H20, and dialyzed for 6 h vs H20. Fractions 
were sterilized by UV irradiation before assay. 
Heparin-sephrose CL-6B affinity chromatography 
Three hundred micrograms DEAE Bio-Gel A fraction 
" was applied to a heparin-sepharose CL6B column 
prepared as follows: One gram heparin-sepharose was 
allowed to swell in 50 ml distilled H20 and the slurry 
poured to form a 5-cm x 2-cm column. The column was 
washed extensively with 200 ml distilled H20 and equil-
ibrated with 20 m1 5 roM Trls-HCI, pH 7.6 before appli-
cation of the sample. Following adsorption of the 
fraction, the column was washed with 20 ml 5 roM Tris-
HCI, pH 7.6, and the activity eluted with 100 roM NaCI:5 
mM Tris-HCI, pH 7.6. Two-milliliter fractions were col-
lected. The peak fractions as determined by absorbance 
at 280 nm were combined, lyophilized, dissolved in H20, 
and dialyzed for 18 h vs H20. The fractions were steri-
lized by UV irradiation before assay. 
Physicochemical treatments of DEAE Bio-Gel 
fraction " 
To test for sensitivity to trypsin, an aliquot was incu-
bated at 37°C for 30 min at a concentration of " ",g 
enzyme per 1 ",g factor. The reaction was stopped by the 
addition of 2 ",g soybean trypsin inhibitor/",g trypsin. 
Sensitivity to papain and protease was determined by 
treating the factor at 37°C for 30 min at the same 
concentration of" ",g enzymel",g factor. For neuramin-
idase treatment, 50 I'i factor was exposed to 0.5 units of 
enzyme. The enzymes were inactivated by heating at 
90°C for 30 min. An aliquot was also heated at 90°C for 
30 min to determine heat lability. In order to test for 
acid sensitivity, an aliquot was brought to 1 M HCI and 
left at room temperature for 1 h, followed by neutrali-
zation of the fraction. All fractions were sterilized by 
UV irradiation before bioassay. 
SOS polyacrylamide gel electrophoresis 
80S-PAGE was performed essentially according to 
Laemmli (1970), using a 1.5 mm thick slab gel. The 
separating gel was 1()'1, acrylamide aDd the stacking gel 
R~K Electrophoresis was performed at 6 mA for 18 h, 
using the buffer system of Laemmli (1970). Gels were 
'The final serum concentration was 2.5"'. 
2Values are the averages ~ six determinations ± SD. 
stained for 2 h in 0.25% Coomassie blue R250: 50% 
methanol: 10% acetic acid and destained in 50% metha-
nol: 10% acetic acid for 1 h and R~ methanol: 5% acetic 
acid for 8 h. 
RESULTS 
It appears that HTC cells release an autocrine factor 
into the medium. HTC cell conditioned medium stimu-
lated [3H]thymidine incorporation when added to newly 
plated cells, as shown in Table 1. The stimulation was 
dose-dependent and was specific for HTC cells. Clone 9 
cells, a liver-derived epithelial-like cell line, did not re-
spond with increased [3H]thymidine incorporation to 
HTC cell conditioned medium. The activity could be 
extracted from the conditioned medium by ethanol pre-
cipitation and has been further purified. The factor could 
also be extracted from HTC cells by homogenization and 
ethanol precipitation of a postmicrosomal supernatant, 
as described in Materials and Methods, and most of our 
work has been done with factor extracted from the cells 
directly. 
By heating the dissolved ethanol precipitate at saoc 
for 10 min, a modest purification could be obtained with 
the activity in the BOoC supernatant. Addition of this 
fraction to HTC cells resulted in a several-fold stimula-
tion of [3H]thymidine incorporation. As can be seen in 
Figure I, slight stimulation was apparent at 12 h of 
exposure to the factor with maximal stimulation occur-
ring between 18 and 48 h of exposure. The cells were 
grown in regular growth medium roME supplemented 
with 10% FBS) and the cells were exposed to 
[3H]thymidine for 2 h prior to harvest, as indicated on 
the abscissa. It can also be seen from the data in Figure 
1 that most of the newly plated cells seem to be in a lag 
phase for the first 12 to 15 h after plating. At 18 h after 
plating, many more cells seem to enter the S phase, and 
it is only at this time, or following 18 h in culture, that 
the cells respond to the factor, even though the factor 
was present from the time of plating. We conf'll'Uled the 
[3H]thymidine incorporation studies by autoradiogra-
phy. Dishes were processed for autoradiography after a 
2·h pulse with [3H]thymidine. Between 2 and 12 h after 
plating, around 1T~ of the cells were labeled, regardless 
of whether the factor was present or absent. By 18 h in 
culture, many more cells had entered the 8 period, and 
the etTect of the factor became apparent. Without factor, 
"9~ of the cells were labeled at 18 h, and this had 
increased to 76% when the factor had been present from 
the time of plating. At 24 and 48 h in culture, about 3()Cl, 
of the cells were labeled with no exogenous factor added, 
and around 6()tI, were labeled in the presence of the 
factor. In addition, the presence of the f'actor resulted in 
a significant increase in the number of grains per nu-
i 
f 
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cleus over the number found when no factor was pres-
ent. The number of grains per nucleus was not affected 
by the presence of the factor during the first 12 h after 
plating. 
A dose response curve is shown in Figure 2. Two 
different fractions were used in these experiments. There 
is a good dose response between 10 and 100 "g/dish of 
T 
f~ -
- "'. /~:~-
T ~~K 
I .-
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Fig. 1. Incorporation of [3H)thymidine at various times after factor 
addition. HTC cells were plated at a density of 5 x 10· cells per 35-
mm dish ± 50 /Lglml of sooe supernatant, in complete medium supple-
mented with 10% FBS. For each time point, control dishes and dishes 
with factor were exposed for 2 h to 0.4 I'Ci [3HJthymidine per dish. 
Cells were harvested and [3Hlthymidine incorporation was determined 
at indicated times. 0, Control dishes;., addition ofSOoC supernatant. 
Each point represents the average of three determinations, with the 
SO indicated by the vertical bars. 
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80°C supernatant and between 1 and 10 "gldish of frac-
tion 4 from a DEAE Bio-Gel A column, which represents 
the next step in the purification scheme. The results 
shown in Figure 2 also indicate that the factor does not 
stimulate [3H]thymidine incorporation in Clone 9 cells, 
a rat liver-derived epithelial-like cell nne, thus indicat-
ing the specificity of this factor. 
As already mentioned, the 80°C supernatant was ap-
plied to a DEAE Bio-Gel A column, and the activity was 
recovered in fraction 4. The elution profile is shown in 
Figure 3. Fractions 1 and 2 had no activity, but fraction 
3 had some activity. The specific activity in fraction 3 
was between 10 and 20% of the specific activity found in 
fraction 4. 
Purification to apparent homogeneity could be 
achieved by applying the DEAE Bio-Gel fraction 4 to a 
heparin-sepharose CL-6B affinity column. As can be seen 
in the elution profile in Figure 4, most of the material 
applied passed through the column, but most of the 
activity associated with a small amount of protein eluted 
with 100 mM NaCI in absorbance peak. IT. The material 
in the tubes under the absorbance peaks was pooled, 
concentrated, and assayed. Despite a large difference in 
the absorbance profile between fractions I and II, there 
was only three times more protein in fraction I than in 
fraction II, but the specific activity of fraction II was ten 
times higher than that of fraction I. Application of this 
material to an SDS polyacrylamide gel and staining 
with Coomassie blue resulted in a single band migrating 
to a Mr of about 60,000, as shown in Figure 5. That the 
biological activity is indeed associated with a molecule 
of this size was confirmed by passing the heparin-se-
pharose fraction IT through a Sephadex G-200 column. 
The activity eluted at the same position as a bovine 
serum albumin standard, and no activity eluted in later 
I;o-G" f 4 
• 
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Fig. 2. Dose response of HTC and Clone 9 ceUs. Assay conditions were as described for Figure 
1 but all dishes were exposed to 0.4 I'Ci (3Hlthymidine from 46 to 48 h after plating and 
addition of growth factor. Both cell types were seeded at the same density of 5 x lQ4 cells per 
dish. The numbers on the abscissa indicate the protein added per dish. Each point represent. 
the average of at least three determinations, with individual values within R~ of the mean. 
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fractions, including fractions containing EGF as a stan-
dard. Furthermore, commercially obtained growth fac-
tors, including EGF, multiplication stimulatory activity 
(MSA), fibroblast growth factor (FGF), and platelet-de-
rived growth factor (PooF), did not stimulate 
[3H)thymidine incorporation under our assay conditions. 
elutes from the columns in the same positions as the cell 
extract activity on further purification. A comparison of 
the specific activities in the DEAE Bio-Gel fraction 4 
and the heparin-sepharose fraction II obtained from cell 
extracts or from conditioned medium is shown in Table 
3. 
The activities in the various fractions and the increase 
in specific activity is shown in Table 2. We have so far 
achieved a purification of 640-fold with the postmicroso-
mal supernatant as the starting material. A similar 
purification of the activity found in the conditioned me-
dium can also be achieved. The activity can be precipi-
tated from the medium by the addition of ethanol and 
The autocrine factor also stimulated an increase in 
cell number, as can be seen from the results in Figure 6. 
The fU"st significant difference in cell number, when 
control cultures were compared with cultures in the 
presence of the factor, was apparent after 72 h in cul-
ture. The difference in cell number increased until day 
5, at which time the dishes were confluent. In control 
O.IOM ...a O.25M NeCl 
1 1 
• 
5 
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IS 
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Fig. 3. Elution profile of DEAE Bio-Gel A chromatography. The activity was recovered in 
fraction 4. Four milligrams protein ofSOoC supernatant were applied to a 10 cm x 1 em column 
equilibrated with 5 mM Tris - HCI. pH 7.6. Four milliliter fractions were collected. Following 
adsorption of the sample the column was washed with 20 ml 5 mM Tris - HC\, pH 7.6 and 
eluted stepwise with 20 ml each: 100 mM NaCI. 250 mM NaCI. and 500 mM NaCI each in 5 
mM Tris, pH 7.6. 
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Fig. 4. Elution profile ofheparin·sepharoee affinity chromatography. The activity eluted in 
fraction n. Three hundred micrograms DEAE Bio-Gel A fraction 4 were applied to a heparin· 
aepharoae CL-6B column prepared as deaeribed in Materiala and Methods. FollowiJli adaorp-
tion of the fraction the column was waabed with 20 ml 5 mM Tris - HCI, pH 7.8 and the 
activity eluted with 100 mM NaCI: 15 mM rea-HCl. pH 7.8. Two millimeter fractions were 
collected. 
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dishes, there was no increase in cell number during the 
first 24 h. At 48 h, the cell number per dish had in-
creased from 25,000 to 42,000, and they then doubled 
every 24 h. The values shown in Figure 6 indicate the 
difference between control dishes and dishes that con-
tained 5 "g/dish of the Bio-Gel F4. An even greater 
difference in cell number resulted when dishes were 
refed after 72 h in culture with the autocrine factor. 
Some physical properties of the factor are shown in 
Table 4. The activity was destroyed by treatment with 
trypsin, papain, or protease, but was not affected by acid 
treatment, heat treatment, or by neuraminidase. In fact, 
acid treatment enhanced the activity. 
92 
66 
45 
31 
21 
14 
2 3 4 5 6 
, I Further evidence for the autocrine nature of the growth factor is provided by the results shown in Table 
5. Despite our finding that the factor can also be ex-
tracted from Clone 9 cells, these cells did not respond to 
the factor, whether Clone 9 cells or HTC cells were the 
source of the extract. HTC cells, on the other hand, 
responded to factor obtained from Clone 9 cells. Several 
Fig. 5. SDS polyacrylamide gel electrophoresis of the autocrine 
factor. Lanes 1 and 6, low Mr standards; lane 2, heparin-sepharose ro, 
20 p,g; lane 3, Bio-Gel F4, 50 p,g; lane 4, 80·C supernatant, 30 p,g; lane 
5, 8O·C supernatant, 10 p,g. 
TABLE 2. Specific activity at various steps during the purification 
[3H lThymidine 
Specific 
Total protein Protein activity 
per fraction added incorporation (unitslmg 
Fraction (mg) (p.g/dish) (cpmllOS cells) protein) 
No addition 0 0 1,328 ± 472 
PMS3 80 100 3,864 ± 129 39 
70% ethanol 25 100 5,178 ± 112 52 
precipitate 
8O·C 15 50 5,776 ± 202 116 
supernatant 
DEAE 0.15 5 9,812 ± 248 2,962 
Bio-Gel F4 
Heparin- 0.010 0.5 12,480 ± 212 24,960 
sepharose FII 
'One unit is defined as !he incorporation of 1,000 cpm ('HJthymidine per lOS cells. 
2Values are the averll&" 01 duplicate dishes from at least three separate experiments ± SO when applicable. 
'P08tmicrosomal supernatant. 
TABLE 3. Stimulation of r3Hlthymidine incorporation by purified fractions from cell extracts and from 
conditioned medium in HTC cells 
Fraction 
None 
DEAE Bio-Gel F4 
Heparin-sepharose FII 
Amount 
added 
(pg) 
o 
5 
0.5 
[3H]Thymidine incorporation (cpmllOs cells) 
Cell extract Conditioned medium 
1,289 ± 961 
9,586 ± 720 7,795 ± 325 
12,480 ± 1,490 11,345 ± 860 
'V.lues are t'>e average of duplicate dishes for three separate experiments ± SO. 
TABLE 4. Physicochemical properties of the factor 
Amount (3H]Thymidine Activity 
Treatment or added incorporation after treatment 
Bio-Gel F4 (pg) (cpml105 cells) (%) 
None 5 7,275 1 100 
Trypsin 5 2,309 32 
Papain 5 3,771 52 
Protease 5 100 1 
Neuraminidase 5 7,816 107 
IMHCI 5 12,560 173 
9O"C30 min 5 7,451 102 
IVaJues are the aver.ges of duplic.te dbbes for three separate experimenta. A control value 011,250 cpmllOS cell. with 
no additions baa been 8Ubtractecl from !he experimental v.lues to give theae v.l .... 
Total 
units l 
3,120 
1,300 
1,740 
294 
250 
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TABLE 5. 9rowth factor activity with differen~t~ce~l~l-I-po-DopI--u~lcK::a-I-ti:KK:oK:c:ns::KF _____________ _ 
Source of growth factor 
HTC cells Clone 9 cells 
Cell (unitslmg proteinf (unitslmg protein) 
bioassay BODC Supernatant Bio-Gel F4 80'C Supernatant Bio-Gel F4 
HTC 96 1,342 39 520 
Clone 9 14 6 13 5 
Hepatocytes in 2 0 1 3 
primary culture 
5 11 BHK <baby hamster 16 13 
kidney cells) 
7 0 L-cells 6 8 
Novikoff hepatoma 2 8 1 4 
IThe cell bioassay is similar r ... all cell lines, with each cell line requiring its own medium. BHK cells, DME: f~ 
tryptose phosphate broth: 5'1 ....... 'horn calf serum; L-ceJIs, DME: 4'1 newborn calf serum; and NovikofT hepatoma cells, 
DME: 5% calf serum. The isolation and incubation conditions for hepatocytes in prImary culture were as described by 
Francavilla et a!., 1986. The values are the averages of duplicate dishes from at least three separate experiments. 
'One unit is defined as the incorporation of 1,000 cpm (3Jilthymidine per lOS cells . 
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Fig. 6. Stimulation.of cell proliferation. HTC cells were subcultured 
and distributed at a cell density of 1.25 x lot cella per 35·mm dishes 
in complete medium ± 5 '" Bio-Gel fraction 4. No medium changes 
were made, and cells were dispersed by trypsin b"eatment at indicated 
times and counted with a Coulter counter. On day 3, some of the 
experimental dishes received an additional 5 ,.g factor. The values 
indicated were expressed 88 cell number in experimental dishes min .. 
cell number in control dishes and were from duplicate determinatioDl 
for each point. 
other cell types, including hepatocytes in primary cul-
ture and Novikotr hepatoma cells, did not respond to the 
factor with increased DNA synthesis. 
'Ib gain some insight into the mechanism and the time 
course of the stimulation, we removed the factor at 2 
'! 
... 
I 
l 
.. 
• N 
'0 
:: 6 
c 
.! 
i 
~ 
.! 4 
• C 
:; 
'i ,.. 
~ 
r-i" 
r::!.....t 
0-5 
Ti", •• f ."polur. t. f.".r (h I 
Fig. 7. DNA synthesis after short·term exposure to the factor. Assay 
conditions were 88 described in Figure 1. After 2 and 5 h, medium was 
removed from control and experimental dishes, the dishes were washed 
once, and complete medium without factor was added to both control 
and experimental dishes. Cells were exposed to eHjthymidine from 
46-48 h. The values indicated are the averages of five determinations 
with the SO. Open bar, control dishes; shaded bar, + 50 ,.gIml SO·C 
supernatant. 
and 5 h after the cells had been plated and the factor 
added. As can be seen from the results in Figure 7, this 
short exposure was sufficient for stimulation of DNA 
synthesis, which was determined 48 h after plating. We 
also added the factor at various times after plating and 
determined DNA synthesis after 48 b in culture. These 
results are shown in Figure 8. Stimulation of DNA syn-
thesis was similar, whether the factor was added at 0 
time or as late as 36 h after plating. Also shown in 
Figure 8 is the finding that the stimulation was com-
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Fig. 8. Inhibition of DNA synthesis by hydroxyurea. Cells were plated as described in Figure 
1. Five micrograms of Bio-Gel fraction 4 were added at indicated times. Hydroxyurea 00 mM 
final concentration) was added at 0 time to controls and at times indicated on the abscissa to 
the experimental dishes. All dishes received [3H)thymidine between 46-48 h. The values are 
the averages of five determinations with the SD. Shaded bar, - hydroxyurea; open bar, + 
hydroxyurea. 
TABLE 6. Stimulation of DNA synthesis after brief exposure to factor 
and its inhibition by hydroxyurea' 
Time of (3H)Thymidine incorporation 
[3H)thymidine (cpmll05 cells) 
exposure Hydroxyurea Bio-Gel F4 
(h) (10 mM) No addition (5 "g/dish) 
0-2 1,410 ± 42 1.385 ± 35 
10-12 1.326 ± 39 1,789 ± 57 
22-24 1,286 ± 31 8,679 ± 250 
22-24 + 637 ± 7 890 ± 9 
46-48 1,486 ± 47 9,970 ± 231 
46-48 + 912 ± 10 967 ± 12 
'The growth fac:Ulr and hydroxyurea. where indicated. were present only during 
the 2 h of eXpa8ure of the ffI'C cells to ('Hlthymidine. The values are the 
averages of five determinations ± SD. 
pletely abolished in the presence of 10 mM hydroxyurea, 
which was added at the time factor additions were made. 
Even more striking were the results shown in Table 6. 
These results indicate that stimulation of DNA synthe· 
sis by the factor was very rapid. The presence of the 
factor, exclusively during the 2-h exposure to 
[3H)thymidine, was sufficient to elicit a full response, 
provided this 2·h exposure was done after the cells had 
established themselves in culture for 18 h. No, or very 
little, stimulation occurred when cells were exposed for 
2 h in the presence of factor during the fll'st 12 h after 
plating. It seems that the cells in the culture must be 
actively growing before this rapid stimulation can occur. 
We have demonstrated that a factor can be extracted 
from HTC-SR cells, which meets the criteria of an "au-
tocrine factor," since it stimulated DNA synthesis and 
growth of the same HTC cells that produced it but had 
no effect on several other cell lines. Our results suggest 
that proliferation in at least this tumor-derived cell line 
might be regulated by an autocrine growth factor. 
DISCUSSION 
The growth factor isolated from HTC-SR cells has in 
common with other growth and transforming factors its 
stability to heat and acid treatment, but differs on the 
basis of its estimated molecular weight from the well-
characterized TGF (Todaro et aI., 1980; Marquardt and 
Todaro, 1982; Halper and Moses, 1983; Richmond et aI., 
1983) and PDGF-like molecules (])eVare et aI., 1983; 
Johnsson et aI., 1984; Bowen-Pope et al. 1984; Owen et 
al., 1984). Our factor seems to be a larger molecule than 
many of the growth factors characterized. It is unlikely 
that the activity in our heparin-sepharose FII is due to 
a smaIl molecule present in nanogram amounts, since 
upon gel filtration on Sephadex G-200, the activity 
eluted at the same position as a bovine serum albumin 
standard, with no activity evident in later fractions. In 
addition, the activity could not be dissociated into a 
small molecule by treatment with acid. In the last few 
years, evidence has been provided for the autocrine hy-
pothesis, first formulated by Sporn and Todaro (1980). 
Using SSV-transformed cells, Huang et a1. (1984) pro-
vided evidence in support of a mechanism in SSV-NIH 
3T3 and SSV-NRK cells whereby autocrine stimulation 
of DNA synthesis and cell growth res~ted from secre-
tion oCthe transforming protein p 28V -BlS, acting through 
external PDGF/p 28v-s18 cell surface receptors. A similar 
relationship exists between type TGF -a and the EGF 
receptors (l)eLarco and Todaro, 1978; Todaro et aI., 1980). 
We have no direct evidence that our autocrine factor 
binds to receptors and might be internalized, but our 
results suggest that a ligand-receptor interaction is im-
portant for the action of our growth factor. Our finding 
that Clone 9 cells produce small amounts of the factor, 
but do not respond with increased DNA synthesis to 
their own factor nor to the factor extracted from the 
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HTC cells, whereas HTC cells respond to both factors, 
suggests that the HTC cells bind and/or internalize the 
factor and that Clone 9 cells do not. 
Our factor also differs from TGF and PDGF-like mol-
ecules on the basis of its specificity. Most growth factors 
described are active on a variety of ditTerent cell lines, 
but as far as we have determined, our factor seems to be 
specific for HTC-SR cells. Although we have not inves-
tigated a wide variety of different neoplastic cell lines, 
NovikotT hepatoma cells, which might be expected to 
have characteristics similar to IITC cells, did not re-
spond to the factor. As yet, we have not attempted to 
extract a similar factor from NovikotT hepatoma cells. 
The amount of heparin-sepharose FIT needed to show 
significant stimulation of DNA synthesis is 100 ng/ml. 
Many of the well-characterized growth factors are active 
at a lower concentration. It is quite possible that the 
factor is active at lower concentrations, but this is diffi-
cult to detect in our assay system. The HTC cells are 
proliferating at a fast rate, and they also produce the 
factor endogenously. It would, therefore, be difficult to 
detect stimulation by exogenous factor at nanogram 
amounts. 
For most of our assays, we have added the factor when 
the cells were plated. DNA synthesis was determined 
48 h later. However, the factor needs to be present for 
only a short time to elicit a comparative response, as 
indicated by the results in Figure 7. Similarly, the factor 
could be added at any time, up to the time of the 2-h 
exposure to eH]thymidine at 46 h after plating and 
DNA synthesis was stimulated. The finding that be-
tween 18 and 48 h in culture, when the cells were ac-
tively growing, the factor needed to be present only 
during the duration of a 2-h exposure, as shown in Table 
4, indicates that the factor stimulates DNA synthesis 
directly. This was also confirmed by our finding that the 
stimulation due to the factor, whether present for 48 h 
or for only 2 h, was completely inhibited by 10 roM 
hydroxyurea. The results with autoradiographY suggest 
that the factor enhances the number of cells entering 
the S period and also seems to initiate the activation of 
additional replication sites as the number of grains per 
nucleus was increased in its presence. 
There was, however, no instantaneous response dur-
ing the fU'st 12 h in culture when cells were exposed to 
the factor during a 2-h exposure to r3H]thymidine, as 
shown in Table 4. Before the cells were plated, they 
were detached from stock. culture dishes by trypsin 
treatment, and it appears that this treatment induces a 
lag period in the newly seeded cultures. This also seems 
to account for our finding that the cell population does 
not double during the first 24 h in culture as was ob-
served at any time after 24 h in culture. On the other 
hand, the trypsin treatment does not seem to alter the 
ability of the cells to bind the factor or to internalize it. 
A 2-h exposure to the factor at the time of plating did 
not result in an immediate stimulation of DNA synthe-
sis, but the cells were apparently programmed for in-
creased DNA synthesis which could be detected when 
DNA synthesis was measured after 18 h or later in 
culture. 
The possibility must be considered that the factor 
might not be a true "growth factor" but a permissive 
factor required for optimal growth, such as an attach-
ment or spreading factor. This seems unlikely, however, 
since the HTC cells grow rapidly in the absence of the 
------
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factors, and the presence of the factor does not seem to 
shorten the lag period following plating. In addition, the 
finding that the factor can stimulate DNA synthesis 
rapidly is inconsistent with the action of spreading or 
attachment factors. Observation with the light micro-
scope did not indicate any etTect of the factor on the 
morphological appearance of the cells. 
At present, we do not know by what mechanism our 
factor induces DNA synthesis. We assume, that at the 
cellular level the factor binds to receptors and might be 
internalized by receptor mediated endocytosis. To pro-
vide evidence for such an occurrence will be our next 
goal. The fact that the factor's action is inhibited by 
hydroxyurea and the rapidity of the response when the 
factor is added to actively growing cells suggests that 
DNA synthesis might be affected directly. 
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